How does ER/PR and Her2/Neu status affect the MR characteristics of invasive ductal carcinoma?

被引：0
|
作者：
Jansen S A [1 ]
Shimauchi A [1 ]
Karczmar G S [1 ]
Newstead G [1 ]
机构：
[1] Univ Chicago, Chicago, IL USA
来源：
BREAST CANCER RESEARCH AND TREATMENT | 2007年 / 106卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：S42 / S42
页数：1
相关论文
共 50 条
  • [1] Immunohistochemical Expression of ER, PR and HER2/neu in Endometrial Carcinoma
    Kaustav Mohapatra
    Sheela devi C. Shivalingaiah
    Indian Journal of Gynecologic Oncology, 2019, 17
  • [2] Immunohistochemical Expression of ER, PR and HER2/neu in Endometrial Carcinoma
    Mohapatra, Kaustav
    Shivalingaiah, Sheela Devi C.
    INDIAN JOURNAL OF GYNECOLOGIC ONCOLOGY, 2019, 17 (03)
  • [3] ER, PR, and HER2/neu in endometrial carcinoma - a clinicopathological study
    Duggal, J.
    Kaur, M.
    BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY, 2019, 126 : 93 - 93
  • [4] Dynamic MR Imaging of Invasive Ductal Carcinoma: Studying Kinetics by Estrogen Receptor, Progesterone Receptor and Her2/Neu Amplification Status
    Arkani, S.
    Newstead, G.
    Abe, H.
    Shimauchi, A.
    Karczmar, G.
    AMERICAN JOURNAL OF ROENTGENOLOGY, 2007, 188 (05)
  • [5] The concordance of estrogen and progesterone receptor status (ER-PR) and HER2/neu expression in DCIS coexistent with micro-invasive and invasive carcinoma
    Ali-Fehmi, R.
    Nahleh, Z. A.
    Ahmed, Q.
    Sethi, S.
    Sakr, W.
    Hussein, Y.
    Ibrahim, M.
    Albashiti, B.
    Hayek, K.
    Bandyopadhyay, S.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [6] The evaluation of the immunoexpression of Her2/neu oncoprotein in ductal carcinoma in situ in association with invasive ductal carcinoma of the breast
    Fota, Georgiana Luminita
    Stepan, A.
    Ciurea, Raluca Niculina
    ROMANIAN JOURNAL OF MORPHOLOGY AND EMBRYOLOGY, 2012, 53 (03): : 805 - 810
  • [7] Clinicopathologic analysis of ER/PR positive and HER2/neu positive breast carcinoma
    Bui, M.
    Laronga, C.
    Hoover, S.
    Acs, G.
    MODERN PATHOLOGY, 2008, 21 : 25A - 25A
  • [8] Clinicopathologic analysis of ER/PR positive and HER2/neu positive breast carcinoma
    Bui, M.
    Laronga, C.
    Hoover, S.
    Acs, G.
    LABORATORY INVESTIGATION, 2008, 88 : 25A - 25A
  • [9] Her2 gene status in breast"in situ" and invasive ductal carcinoma
    Cozaru, G. C.
    Mitroi, A. F.
    Aschie, M.
    Brinzan, C. S.
    Poinareanu, I.
    EUROPEAN JOURNAL OF HUMAN GENETICS, 2018, 26 : 968 - 969
  • [10] Expressions of ER, PR, Her2/neu and Ki-67 and their correlation in 55 cases of infiltrating ductal carcinoma of the breast
    Zhang, SL
    Schinella, R
    JOURNAL OF TUMOR MARKER ONCOLOGY, 2000, 15 (02): : 123 - 127
12345